The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study.
Jamy D ArdIan J NeelandAmy E RothbergRobert J ChiltonDaniel de LuisSarah S CohenOdd Erik JohansenPublished in: Diabetes, obesity & metabolism (2023)
In people with obesity at low ASCVD risk, OP significantly reduced cardiovascular risk factors and 10-year predicted risk for ASCVD.